Skip to content

Pilon Fracture Reduction and Functional Outcome

Quality of Fracture Reduction and Its Influence on Functional Outcome in Patients With Pilon Fractures - a Prospective Multicenter Case Series

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01316289
Enrollment
117
Registered
2011-03-16
Start date
2011-11-30
Completion date
2017-03-31
Last updated
2020-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilon Fracture of Tibia

Keywords

tibial fractures, pilon, pilon fractures, tibial plafond, reduction quality, anatomical reduction, functional outcome, ankle joint

Brief summary

This prospective case series will essentially examine the influence of reduction quality on the primary functional outcome (as assessed using the FAAM) of patients with pilon fractures treated with plate fixation. The plates used in this trial can be chosen according to the preferences of the surgeon.

Detailed description

A prospective case series to examine the influence of reduction quality on the primary functional outcome (as assessed using the FAAM) of patients with pilon fractures treated with plate fixation. Radiological parameters including single/combined alignment and various articular measurements will also be validated according to their reliability. The sensitivity of the effects of reduction quality on functional outcome, and an extended evaluation of patient-rated functional and social outcomes as well as their outcome expectations will also be assessed as part of the secondary study aims.

Interventions

None listed

Sponsors

AO Clinical Investigation and Publishing Documentation
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years and older * Patients with a unilateral intraarticular pilon fracture of the distal tibia classified according to AO: AO 43 - B1, B2 and B3 (partial intraarticular) AO 43 - C1, C2 and C3 (total intraarticular) * Definitive fracture fixation with a plate within 4 weeks after accident (Temporary fixation with an external fixator, cast or traction is allowed) * Signed written informed consent (by the patients) and agreement to attend the planned FU evaluations

Exclusion criteria

* Contralateral fracture of the distal half of the tibia/fibula/talus * Pathologic fracture * Severe Polytrauma: Injury Severity Score (ISS) \> 28 * Preexisting severe vascular disease (chronic venous insufficiency, chronic arterial occlusive disease) * Drug or alcohol abuse * American Society of Anesthesiologists (ASA) class V and VI * Inability to walk independently prior to injury event * Neurological and psychiatric disorders that would preclude reliable assessment

Design outcomes

Primary

MeasureTime frameDescription
Examine the influence of reduction quality on the primary functional outcome (as assessed using the Foot and Ankle Ability Measure (FAAM)) of patients with pilon fractures treated with plate fixation.2 yearsThe most important predictors of functional outcome after pilon fracture will be identified by evaluating the influence of radiologically assessed parameters of reduction quality and other factors (age, high/low energy trauma, AO fracture type, open/closed fracture, delay between trauma and definitive fracture fixation) on the FAAM. In parallel, the radiological parameters will also be validated with respect to their reliability.

Secondary

MeasureTime frameDescription
Surgical details1 year* Length of surgery (skin-to-skin time) * Type of implant used * Use of bone graft * Soft tissue or wound-related procedures (eg, debridement, free flap, local flap, split skin graft)
Pre- and postoperative treatment1 yearPerioperative management data will include documentation of the use of thromboprophylaxis or prophylactic antibiotics, therapeutic antibiotics and pain medication including nonsteroidal antiinflammatory drugs (NSAID).
To assess whether patient and surgeon expectations are met with regard to the trauma outcome1 yearTrauma expectations factor (TEF) to assess the patient and surgeon expectations about the outcome of the treatment

Countries

Austria, Brazil, Switzerland, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026